These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Renal involvement in ankylosing spondylitis: prevalence, pathology, response to TNF-a blocker. Lee SH; Lee EJ; Chung SW; Song R; Moon JY; Lee SH; Lim SJ; Lee YA; Hong SJ; Yang HI Rheumatol Int; 2013 Jul; 33(7):1689-92. PubMed ID: 23269570 [TBL] [Abstract][Full Text] [Related]
3. A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients. Pamuk ÖN; Kalyoncu U; Aksu K; Omma A; Pehlivan Y; Çağatay Y; Küçükşahin O; Dönmez S; Çetin GY; Mercan R; Bayındır Ö; Çefle A; Yıldız F; Balkarlı A; Kılıç L; Çakır N; Kısacık B; Öksüz MF; Çobankara V; Onat AM; Sayarlıoğlu M; Öztürk MA; Pamuk GE; Akkoç N Rheumatol Int; 2016 Jul; 36(7):945-53. PubMed ID: 27221456 [TBL] [Abstract][Full Text] [Related]
4. [Response to anti-TNF-alpha treatment for secondary renal amyloidosis in a patient with ankylosing spondylitis]. Bellissimo S; Ferrucci MG; Gallo A; Stisi S Reumatismo; 2007; 59(3):240-3. PubMed ID: 17898885 [TBL] [Abstract][Full Text] [Related]
5. The effect of etanercept on a case of amyloidosis secondary to ankylosing spondylitis: results of 2-year follow-up. Yilmaz H; Kocabas H; Erkin G Acta Reumatol Port; 2013; 38(4):299-301. PubMed ID: 24435036 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of adalimumab in a patient with ankylosing spondylitis on peritoneal dialysis. Kobak S Rheumatol Int; 2012 Jun; 32(6):1785-7. PubMed ID: 20340019 [TBL] [Abstract][Full Text] [Related]
9. Renal amyloidosis in ankylosing spondylitis: A monocentric study and review of literature. Barbouch S; Hajji M; Jaziri F; Aoudia R; Fellah E; Hedri H; Goucha R; Hamida FB; Taarit FB; Gorsane I; Abdallah TB Saudi J Kidney Dis Transpl; 2018; 29(2):386-391. PubMed ID: 29657208 [TBL] [Abstract][Full Text] [Related]
10. Renal AA amyloidosis in a patient with Bence Jones proteinuria and ankylosing spondylitis. Quinton R; Siersema PD; Michiels JJ; ten Kate FJ J Clin Pathol; 1992 Oct; 45(10):934-6. PubMed ID: 1430270 [TBL] [Abstract][Full Text] [Related]
11. Complete Remission of Nephrotic Syndrome Without Resolution of Amyloid Deposit After Anti-Tumor Necrosis Factor α Therapy in a Patient With Ankylosing Spondylitis. Lee YH; Kim EY; Jeong DW; Kim YG; Lee SH; Song R; Yang HI; Lim SJ; Moon JY; Lee SH J Clin Rheumatol; 2016 Mar; 22(2):86-8. PubMed ID: 26906302 [TBL] [Abstract][Full Text] [Related]
13. Proteinuria in children with juvenile idiopathic arthritis: Making the case for early urinary screening. Saha A; Pais P; Iyengar AA; Abraham AK Saudi J Kidney Dis Transpl; 2017; 28(6):1408-1411. PubMed ID: 29265055 [TBL] [Abstract][Full Text] [Related]
14. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience. Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248 [TBL] [Abstract][Full Text] [Related]
15. The permanent improvement of proteinuria and renal failure with colchicine and enalapril in a leukemic patient with renal amyloidosis secondary to ankylosing spondylitis: a review of the literature. Paydas S; Paydas S; Balal M Am J Ther; 2013; 20(4):344-6. PubMed ID: 22975660 [TBL] [Abstract][Full Text] [Related]
16. Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study. Arends S; Brouwer E; van der Veer E; Groen H; Leijsma MK; Houtman PM; Th A Jansen TL; Kallenberg CG; Spoorenberg A Arthritis Res Ther; 2011 Jun; 13(3):R94. PubMed ID: 21689401 [TBL] [Abstract][Full Text] [Related]
17. Ankylosing spondylitis-related secondary amyloidosis responded well to etanercept: a report of three patients. Kobak S; Oksel F; Kabasakal Y; Doganavsargil E Clin Rheumatol; 2007 Dec; 26(12):2191-2194. PubMed ID: 17611708 [TBL] [Abstract][Full Text] [Related]
18. Regression of reactive systemic amyloidosis due to ankylosing spondylitis following the administration of colchicine. Escalante A; Ehresmann GR; Quismorio FP Arthritis Rheum; 1991 Jul; 34(7):920-2. PubMed ID: 2059239 [TBL] [Abstract][Full Text] [Related]
19. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy. Gottenberg JE; Merle-Vincent F; Bentaberry F; Allanore Y; Berenbaum F; Fautrel B; Combe B; Durbach A; Sibilia J; Dougados M; Mariette X Arthritis Rheum; 2003 Jul; 48(7):2019-24. PubMed ID: 12847696 [TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory profile of renal amyloidosis: A single-center experience. Engineer DP; Kute VB; Patel HV; Shah PR Saudi J Kidney Dis Transpl; 2018; 29(5):1065-1072. PubMed ID: 30381502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]